IB
Infinity Bio, Inc.
SEC filingOther Health Care · Baltimore, MD
Amount raised$5Msold at filing
Total offering$7M$2M still open
Investors in the raise1count reported to the SEC
FiledAug 20, 2025first sale Jun 13, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Bill Benjamin CampbellDirector
Caroline PopperDirector
Malek Benjamin FahemDirector
H. Benjamin LarmanExecutive Officer, Director
Herman Benjamin ScholtzDirector
Matthew Benjamin HellauerDirector
Joy NassifExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.